Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: TTE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on TTE, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 1,225,885 TTE shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,225,885 shares
    Change vs previous 13F -204,331 shares

    1.75% of the 13F portfolio, value $95,347,141.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,430,216 shares
    Change vs previous 13F +39,287 shares

    2.57% of the 13F portfolio, value $133,332,083.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,390,929 shares
    Change vs previous 13F not available

    1.91% of the 13F portfolio, value $90,817,761.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).